Trending stocks

Andrew Peller Ltd Debt dropped on 11.1% in 2015 while Revenue increased on 6.0%

03.06.2015 • About Andrew Peller Ltd ($ADW.B) • By InTwits

Andrew Peller Ltd reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • EBITDA Margin is relatively stable: 10.9% in FY2015 vs. 11.3% in FY2014 vs. 11.9% in FY2011
  • Andrew Peller Ltd has low CAPEX intensity: 5 year average CAPEX/Revenue was 3.2%. At the same time it's a lot of higher than industry average of 91.1%.
  • CAPEX is quite volatile: 380 in 2015, 120 in 2014, 124 in 2013, 641 in 2012, 392 in 2011
  • The company has business model with average profitability: ROIC is at 10.2%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Andrew Peller Ltd ($ADW.B) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue265.4276.9289.1297.8315.76.0%
Gross Profit103.3107.3104.6103.0109.05.8%
SG&A76.374.379.77.3%
EBITDA31.532.733.533.734.42.1%
Net Income11.213.014.514.015.28.6%
Balance Sheet
Cash0.00.00.00.00.0
Short Term Debt54.162.966.561.836.7-40.6%
Long Term Debt42.741.541.538.352.336.4%
Cash flow
Capex8.17.312.99.48.5-9.8%
Ratios
Revenue growth0.9%4.3%4.4%3.0%6.0%
EBITDA growth15.3%3.5%2.6%0.7%2.1%
Gross Margin38.9%38.7%36.2%34.6%34.5%-0.1%
EBITDA Margin11.9%11.8%11.6%11.3%10.9%-0.4%
Net Income Margin4.2%4.7%5.0%4.7%4.8%0.1%
SG&A, % of revenue26.4%24.9%25.2%0.3%
CAPEX, % of revenue3.0%2.6%4.5%3.2%2.7%-0.5%
ROIC10.6%10.8%10.4%10.1%10.2%0.1%
ROE9.8%11.1%11.6%10.5%10.7%0.2%
Net Debt/EBITDA3.1x3.2x3.2x3.0x2.6x-0.4x

Revenue and profitability


Andrew Peller Ltd's Revenue increased on 6.0% in FY2015. EBITDA Margin showed almost no change in FY2015.

Gross Margin showed almost no change in FY2015. SG&A as a % of Revenue showed almost no change in FY2015.

Net Income marign showed almost no change in FY2015.

Capital expenditures (CAPEX) and working capital investments


The company's CAPEX/Revenue was 2.7% in FY2015. The company showed almost no change in CAPEX/Revenue from FY2012 to FY2015. It's average level of CAPEX/Revenue for the last three years was 3.4%.

Return on investment


The company operates at low ROIC (10.19%) and ROE (10.67%). ROIC showed almost no change in FY2015. ROE showed almost no change in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 2.6x and Debt / EBITDA is 2.6x. Net Debt / EBITDA dropped on 0.4x from 3.0x to 2.6x in FY2015. Debt dropped on 11.1% in FY2015 while cash didn't change in FY2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below you can find Andrew Peller Ltd benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)10.9%8.7%6.9%13.2%0.9%
Andrew Peller Ltd ($ADW.B)4.3%4.4%3.0%6.0%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (73 companies)33.7%35.8%35.5%35.6%28.3%
Andrew Peller Ltd ($ADW.B)38.9%38.7%36.2%34.6%34.5%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)7.9%7.9%8.3%10.5%-195.9%
Andrew Peller Ltd ($ADW.B)11.9%11.8%11.6%11.3%10.9%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
 
Median (85 companies)2.3%2.6%2.4%2.4%14.4%
Andrew Peller Ltd ($ADW.B)3.0%2.6%4.5%3.2%2.7%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)7.4%6.7%6.7%6.9%-10.5%
Andrew Peller Ltd ($ADW.B)10.6%10.8%10.4%10.1%10.2%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (69 companies)1.8x2.5x2.1x2.7x0.9x
Andrew Peller Ltd ($ADW.B)3.1x3.2x3.2x3.0x2.6x